About the Authors
- Rémy Boussageon
-
Affiliation Department of General Medicine, Université Claude Bernard Lyon 1, Lyon, France
- Irène Supper
-
Affiliation Department of General Medicine, Université Claude Bernard Lyon 1, Lyon, France
- Theodora Bejan-Angoulvant
-
Affiliations Service de Pharmacologie Clinique, Centre Hospitalier Régional et Universitaire de Tours, France, UMR 7292, CNRS, Université François Rabelais, Tours, France
- Nadir Kellou
-
Affiliation Department of General Medicine, Université Claude Bernard Lyon 1, Lyon, France
- Michel Cucherat
-
Affiliations UMR 5558, CNRS, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France, Université Claude Bernard Lyon 1, Lyon, France
- Jean-Pierre Boissel
-
Affiliations UMR 5558, CNRS, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France, Université Claude Bernard Lyon 1, Lyon, France
- Behrouz Kassai
-
Affiliations UMR 5558, CNRS, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France, Université Claude Bernard Lyon 1, Lyon, France, Clinical Investigation Centre, INSERM CIC201, Lyon, France, Department of Clinical Pharmacology, Hospices Civils de Lyon, Lyon, France
- Alain Moreau
-
Affiliation Department of General Medicine, Université Claude Bernard Lyon 1, Lyon, France
- François Gueyffier
-
Affiliations UMR 5558, CNRS, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France, Université Claude Bernard Lyon 1, Lyon, France, Clinical Investigation Centre, INSERM CIC201, Lyon, France, Department of Clinical Pharmacology, Hospices Civils de Lyon, Lyon, France
- Catherine Cornu
-
* E-mail: catherine.cornu@chu-lyon.fr
Affiliations UMR 5558, CNRS, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France, Université Claude Bernard Lyon 1, Lyon, France, Clinical Investigation Centre, INSERM CIC201, Lyon, France, Department of Clinical Pharmacology, Hospices Civils de Lyon, Lyon, France
Competing Interests
MC received fees for consulting from BMS and Servier. MC also received fees for speaking from AstraZeneca. All other authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: RB TBA CC FG. Performed the experiments: IS. Analyzed the data: RB CC TBA NK MC JPB BK AM. Wrote the first draft of the manuscript: RB TBA FG CC. Contributed to the writing of the manuscript: RB TBA NK AM FG CC. ICMJE criteria for authorship read and met: RB IS TBA NK MC JPB BK AM FG CC. Agree with manuscript results and conclusions: RB IS TBA NK MC JPB BK AM FG CC.